#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5223843	B	Partial agonist activity at human 5HT4E receptor expressed in CHO cells assessed as cAMP accumulation incubated for 4 hrs by luciferase reporter gene luminescence assay	Homo sapiens	73		cell-based format	Scientific Literature
2.	ALA5223844	B	Partial agonist activity at human 5HT4E receptor expressed in CHO cells assessed as cAMP accumulation incubated for 4 hrs by luciferase reporter gene luminescence assay relative to control	Homo sapiens	68		cell-based format	Scientific Literature
3.	ALA5223845	A	Drug metabolism in rat liver microsomes incubated for 30 mins in presence of NADPH by LC-MS/MS analysis	Rattus norvegicus	26		microsome format	Scientific Literature
4.	ALA5223846	A	Drug metabolism in human liver microsomes incubated for 30 mins in presence of NADPH by LC-MS/MS analysis	Homo sapiens	26		microsome format	Scientific Literature
5.	ALA5223847	T	Inhibition of hERG expressed in HEK293 cells at holding potential of -80 mV by whole cell patch clamp assay	Homo sapiens	11		cell-based format	Scientific Literature
6.	ALA5223848	T	Inhibition of hERG expressed in HEK293 cells at holding potential of -80 mV by whole cell patch clamp assay relative to control	Homo sapiens	11		cell-based format	Scientific Literature
7.	ALA5223849	A	Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate incubated for 2 mins in presence of NADPH regenerating system by LC-MS/MS analysis	Homo sapiens	17		microsome format	Scientific Literature
8.	ALA5223850	A	Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate incubated for 12 mins in presence of NADPH regenerating system by LC-MS/MS analysis	Homo sapiens	17		microsome format	Scientific Literature
9.	ALA5223851	A	Time-dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate in presence of NADPH regenerating system measured after 30 mins by LC-MS/MS analysis	Homo sapiens	13		microsome format	Scientific Literature
10.	ALA5223852	A	Oral bioavailability in Wistar rat at 3 mg/kg measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
11.	ALA5223853	A	Cmax in Wistar rat at 3 mg/kg, po and 1 mg/kg, iv measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
12.	ALA5223854	A	AUC in Wistar rat at 3 mg/kg, po and 1 mg/kg, iv measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
13.	ALA5223855	A	Elimination half life in Wistar rat at 3 mg/kg, po and 1 mg/kg, iv measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
14.	ALA5223856	A	Volume of distribution at steady state in Wistar rat at 3 mg/kg, po and 1 mg/kg, iv measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
15.	ALA5223857	A	Clearance in Wistar rat at 1 mg/kg, iv measured for 24 hrs by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
16.	ALA5223858	A	Ratio of drug level in Wistar rat brain to plasma at 10 mg/kg, po measured after 1 hr by LC-MS/MS analysis	Rattus norvegicus	19		organism-based format	Scientific Literature
17.	ALA5223866	F	Pro-cognitive activity in Wistar rat assessed as attenuation of long-term memory deficit by measuring increase in exploration time for novel object at 1 to 10 mg/kg, po by object recognition test	Rattus norvegicus	1		organism-based format	Scientific Literature
18.	ALA5223869	F	Pro-cognitive activity in Wistar rat assessed as reduction in scopalamine-induced amnesia at 1 to 10 mg/kg, po by radial arm maze test	Rattus norvegicus	2		organism-based format	Scientific Literature